The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys, P. W.; Chichareon, P.; Modolo, R.; Leaman, D. M.; Reiber, J. H. C.; Emanuelsson, H.; Di Mario, C.; Pijls, N. H. J.; Morel, M. -A.; Valgimigli, M.; Farooq, V.; van Klaveren, D.; Capodanno, D.; Andreini, D.; Bourantas, C. V.; Davies, J.; Banning, A. P.; Escaned, J.; Piek, J. J.; Echavarria-Pinto, M.; Taylor, C. A.; Thomsen, B.; Collet, C.; Pompilio, G.; Bartorelli, A. L.; Glocker, B.; Dressler, O.; Stone, G. W.; Onuma, Y.

doi:10.4244/EIJ-D-19-00543B

Following the CABRI1 and ARTS2 trials on multivessel disease, a challenging new trial was proposed to surgeons, namely the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial, sponsored by Boston Scientific as an IDE FDA trial on the use of the TAXUS™ stent (Boston Scientific, Marlborough, MA, USA) in three-vessel disease and left main. Actually, the left main component of the trial was a proposal made by Marie-Claude Morice and Antonio Colombo.

The SYNTAX score on its way out or … towards artificial intelligence: part II / Serruys P.W.; Chichareon P.; Modolo R.; Leaman D.M.; Reiber J.H.C.; Emanuelsson H.; Di Mario C.; Pijls N.H.J.; Morel M.-A.; Valgimigli M.; Farooq V.; van Klaveren D.; Capodanno D.; Andreini D.; Bourantas C.V.; Davies J.; Banning A.P.; Escaned J.; Piek J.J.; Echavarria-Pinto M.; Taylor C.A.; Thomsen B.; Collet C.; Pompilio G.; Bartorelli A.L.; Glocker B.; Dressler O.; Stone G.W.; Onuma Y.. - In: EUROINTERVENTION. - ISSN 1969-6213. - ELETTRONICO. - 16:(2020), pp. 60-75. [10.4244/EIJ-D-19-00543B]